Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Volitionrx Ltd as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +4 vs. Q4 2022
- Shares held
- 6.42M
- +221.5K (+3.6%) vs. Q4 2022
- Total value
- $12.2M
- −$2.83M (−18.8%) vs. Q4 2022
- New holders
- 7
- 12 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 3,775,444 | $7.21M | 5.13% | +20,399+0.5% | Added |
| BlackRock Inc. | 547,808 | $1.05M | 0.00% | +6,712+1.2% | Added |
| Vanguard Group Inc | 505,998 | $966.5K | 0.00% | +2,005+0.4% | Added |
| Geode Capital Management, LLC | 292,726 | $559.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 236,503 | $451.7K | 0.00% | −15,393−6.1% | Reduced |
| Bridgeway Capital Management, LLC | 176,100 | $336.4K | 0.01% | +50,000+39.7% | Added |
| Cowen Prime Advisors LLC | 181,843 | $309.0K | 0.12% | +4,800+2.7% | Added |
| State Street Corp | 123,923 | $236.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 112,894 | $215.6K | 0.00% | +64,722+134.4% | Added |
| Northern Trust Corp | 70,092 | $133.9K | 0.00% | +9,245+15.2% | Added |
| Cerity Partners LLC | 65,000 | $124.2K | 0.00% | +26,974+70.9% | Added |
| Bank of America Corp | 61,000 | $116.5K | 0.00% | +53,066+668.8% | Added |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $106.2K | 0.05% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 37,921 | $72.0K | 0.00% | +37,921 | New |
| Cubist Systematic Strategies, LLC | 30,172 | $57.6K | 0.00% | +30,172 | New |
| Jane Street Group, LLC | 26,194 | $50.0K | 0.00% | +26,194 | New |
| Bank of New York Mellon Corp | 21,627 | $41.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,318 | $38.8K | 0.00% | −61,637−75.2% | Reduced |
| Charles Schwab Investment Management Inc | 15,384 | $29.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,106 | $19.3K | 0.00% | +8,180+424.7% | Added |
| Two Sigma Securities, LLC | 10,081 | $19.3K | 0.00% | −3,189−24.0% | Reduced |
| Sensible Money, LLC | 10,000 | $19.1K | 0.02% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,247 | $12.0K | 0.00% | +1,274+25.6% | Added |
| Hartford Financial Management Inc. | 5,000 | $9.55K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 4,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Credit Agricole S A | 4,000 | $7.64K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2,500 | $4.78K | 0.00% | +2,500 | New |
| Barclays PLC | 2,363 | $4.51K | 0.00% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 2,265 | $4.33K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,000 | $1.91K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 810 | $1.55K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 520 | $993 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 274 | $523 | 0.00% | +5+1.9% | Added |
| BNP Paribas Arbitrage, SA | 265 | $506 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 200 | $382 | 0.00% | +200 | New |
| Point72 Middle East FZE | 185 | $353 | 0.00% | +185 | New |
| Ancora Advisors, LLC | 100 | $191 | 0.00% | +100 | New |
| Adirondack Retirement Specialists, Inc. | 32 | $60 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,510−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −13,131−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |